29.06.2013 Views

NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...

NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...

NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

2000 reported that the average heroin user injects the<br />

drug four or five times per day.<br />

Narcotic Analgesics<br />

Oxycodone<br />

The use of oxycodone products, including OxyContin,<br />

Percocet/Percodan, Roxicet, and Tylox, continues<br />

to appear problematic in Philadelphia.<br />

Oxycodone reports in hospital emergency departments<br />

ranked first among all narcotic analgesics in the unweighted<br />

data accessed from DAWN Live! for the first<br />

half of 2004 (n=400). Among these cases, the plurality<br />

of cases were classified as “overmedication.”<br />

Oxycodone was detected in 369 decedents from 1994<br />

through the first half of 2004 (the ninth most frequently<br />

detected drug during that time period) (exhibit<br />

2). Detections of oxycodone have been rapidly<br />

increasing since 2000. In 2003, oxycodone was present<br />

in 9.6 percent of all drug-positive deaths; in the<br />

first half of 2004, oxycodone was present in 10.9<br />

percent of drug-positive mortality cases.<br />

Focus group participants since spring 2002 reported<br />

the spread of oxycodone use to all racial/ethnic<br />

groups, with an age range of mid-teens to 40, with<br />

the largest user group being people in their twenties.<br />

Hydrocodone<br />

In the unweighted data accessed from DAWN Live!,<br />

hydrocodone ED reports ranked second among all<br />

narcotic analgesics in the first half of 2004 (n=69).<br />

Among these cases, the plurality of cases were classified<br />

as “seeking detox.”<br />

The presence of hydrocodone in mortality cases has<br />

also increased. There were 40 positive toxicology<br />

ME reports for hydrocodone in 2003, 23 reports in<br />

the first half of 2004, and a total of 211 cases in the<br />

10½ -year period from 1994 through June 2004.<br />

Hydrocodone detections now rank 14th among all<br />

deaths with positive toxicology reports.<br />

Opioid Analgesics<br />

Fentanyl<br />

In the spring of 2004, the Pennsylvania State Attorney<br />

General’s Office issued information about the<br />

diversion and nonmedical use of fentanyl citrate. In<br />

particular, Actiq lozenges were cited as being sold on<br />

the streets of Philadelphia for $20 each. Actiq contains<br />

fentanyl citrate and is indicated for patients who<br />

186<br />

<strong>EPIDEMIOLOGIC</strong> TRENDS IN <strong>DRUG</strong> <strong>ABUSE</strong>—Philadelphia<br />

continue to experience pain while being treated with<br />

synthetic opiates. Actiq resembles a lollipop, as the<br />

medication lozenge is at the end of a small stick and<br />

it is used by rubbing against the inside soft tissue of<br />

the mouth. Locally, users call it “Perca-pop” or<br />

“Narco-pop.” From 1994 through 2003, the ME recorded<br />

35 deaths with the presence of fentanyl. Of<br />

these, seven occurred in the first half of 2003, and<br />

nine occurred in the second half of 2003. There were<br />

14 additional mortality cases with positive toxicology<br />

reports for fentanyl in the spring of 2004, the period<br />

of the State Attorney General’s announcement.<br />

Marijuana<br />

Marijuana continued to be readily available and<br />

widely used in Philadelphia in the first half of 2004.<br />

Unweighted data from DAWN Live! show that marijuana<br />

reports in hospital emergency departments<br />

ranked fourth (behind cocaine, alcohol, and heroin)<br />

among all drugs in cases categorized as “seeking detox,”<br />

“overmedication,” or “other” in the first half of<br />

2004 (n=738) (exhibit 1). Among these patients, 64<br />

percent were male, 47 percent were African-American,<br />

45 percent were White, 4 percent were Hispanic, and 4<br />

percent were not specified. Twenty-one to 24-yearolds<br />

accounted for the plurality of patients with 18<br />

percent. The second largest group was 35–44-yearolds,<br />

representing 17 percent.<br />

The proportion of clients who cited marijuana as the<br />

primary drug of abuse upon entering treatment was<br />

17 percent in 2003 and the first half of 2004 (exhibit<br />

4). Among all admissions in 2003 and the first half of<br />

2004, marijuana was mentioned by an additional 10<br />

percent as a secondary drug. During the same time<br />

periods, marijuana was mentioned as a tertiary drug<br />

by 7 percent and 6 percent, respectively. In 2003,<br />

among primary marijuana admissions, males accounted<br />

for 78 percent; African-Americans accounted<br />

for 63 percent, Whites accounted for 21 percent, Hispanics<br />

accounted for 13 percent, and Asians and others<br />

accounted for 3 percent. In the first half of 2004,<br />

the comparable figures were 78 percent male, 63 percent<br />

African-American, 24 percent White, 10 percent<br />

Hispanic, and 2 percent Asian and other. Among<br />

primary marijuana treatment admissions in 2003, the<br />

average number of drugs of abuse noted upon entering<br />

treatment was 1.63. The average in the first half<br />

of 2004 was 1.65.<br />

Urinalysis data of booked arrestees from Philadelphia’s<br />

APPD in the first half of 2004 showed that<br />

18.3 percent (n=4,610) of the 25,178 tested arrestees<br />

in the sample were positive for marijuana or marijuana<br />

metabolites. Marijuana was the most frequently<br />

detected drug by APPD.<br />

Proceedings of the Community Epidemiology Work Group, Vol. II, January 2005

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!